Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-27A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Eptifibatide as Treatment for Acute Pain Episodes in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2013-06-19A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2013-05-08A Pilot Study of Hydroxyurea for the Treatment of Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2013-05-03Phase 1/Phase 2 Study of the Safety, Pharmacokinetics, and Microvascular Effect of Titrating Doses of Intravenous GMI-1070, a Pan-Selectin Inhibitor, in Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2013-04-18Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-04-05Preventing Acute Chest Syndrome by Transfusion Feasibility Study( PROACTIVE Feasibility Study)
-
CLINICAL_TRIALS study record update · 2013-03-12Multi-Center Study Using Allogeneic Stem Cell Transplantation Following Reduced Intensity Chemotherapy in Patients With Hemoglobinopathies
-
CLINICAL_TRIALS study record update · 2013-02-27Kidney Transplantation in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2013-01-31Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2012-12-19Evaluation of the Characteristics, Prevalence and Prognosis of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease: Study ETENDARD.
-
CLINICAL_TRIALS study record update · 2012-12-04An Evaluation of the Effectiveness of Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease: a Double-blind, Placebo-controlled Randomised Trial
-
CLINICAL_TRIALS study record update · 2012-11-06Relative Bioavailability of a Prasugrel Paediatric Orally Disintegrating Tablet Formulation Compared to the Tablet in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2012-07-26Interest of Angiotensin-converting Enzyme Inhibitors on Early Sickle Cell Renal Disease in Children. A Randomized, Double-blind Trial Enalapril vs Placebo.
-
CLINICAL_TRIALS study record update · 2012-02-06A Prospective Randomized Comparative Study of Efficacy and Safety of Combined Deferiprone (DFP) and Deferasirox Versus DFP and Desferrioxamine (DFO) Therapy in Diseases With Severe Iron Overload
-
CLINICAL_TRIALS study record update · 2012-01-04Aspirin Prophylaxis in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2011-11-11Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2011-08-01A Randomized, Blinded, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 in Subjects With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2011-07-18A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 With or Without Hydroxyurea Therapy in Patients With Sickle Cell Anemia
-
CLINICAL_TRIALS study record update · 2011-06-30The Effects of Cytochrome P450 2D6 Genotype on Pain Management With Codeine in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2011-06-06Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
-
CLINICAL_TRIALS study record update · 2011-05-02A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators
-
CLINICAL_TRIALS study record update · 2011-05-02A Randomized, Open-label, Multi-center, Phase II Study to Evaluate the Safety and Efficacy of Deferasirox (ICL670) 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood Transfusions
-
CLINICAL_TRIALS study record update · 2011-01-20A One Year Open Label, Non-comparative Extension to a Randomized, Multicenter, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration (LIC) of Repeated Doses of 5-30mg/kg/Day ICL670 Relative to Deferoxamine (DFO) in Sickle Cell Disease (SCD) Patients With Transfusional Hemosideresis (THS) [Amendment 3: Extension Prolonged to 4-years]
-
CLINICAL_TRIALS study record update · 2010-11-18MACS Study - Microparticles and Coagulation in Sickle Cell Disease: An Observational Study to Measure the Levels of Circulating Microvesicles and Coagulation Activation Parameters in Patients With Sickle Cell Disease in the in- and Out-patient Setting.
-
CLINICAL_TRIALS study record update · 2010-10-25Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)